Bo Xu, MD
Enriched profileStaff cardiologist, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine · Cleveland Clinic
Bo Xu is Staff cardiologist, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. OpenAlex indexes 633 publications with 12,402 citations (h-index 53); ClinicalTrials.gov lists 17 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Bo Xu, M.D., is Staff cardiologist, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic (Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute). The public record shows 633 publications with 12,402 citations (h-index 53), centered on Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 2 companies.
- Most recent indexed publication: 2026 · Angiology
- Top research focus: Coronary Interventions and Diagnostics
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 232.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- The FAVOR V AMI Trial
Sponsor: China National Center for Cardiovascular Diseases
Industry payments
Updated 23 Oct 2026
2 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202514 payments$23,456openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20247 payments
- GE HEALTHCAREProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81%Cardiac Myosin Inhibitor19.2%Camzyos100%Part D≥24 patientsBeta blocker18.3%Metoprolol Succinate82%Carvedilol9%Metoprolol Tartrate9%Part D<11 patients+ 10 more classes in this area
Blood & clotting
11.4%Factor Xa inhibitor10.3%Eliquis100%Part D≥29 patientsP2Y12 inhibitor1.1%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
6.6%SGLT2 inhibitor6.6%Jardiance59%Farxiga41%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 23 Oct 2026
2 congress contributions (2023–2025) across ASH, ESMO per OpenAlex. The most recent:
- Phase 1/2 First-in-Human Study of the Menin-MLL Inhibitor DSP-5336 in Patients with Relapsed or Refractory Acute Leukemia
ASH Annual Meeting
ASH2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Association of left ventricular global longitudinal strain with outcomes of severe mitral regurgitation due to severe mitral annular calcification: a retrospective cohort study.
Cardiovascular diagnosis and therapy
Article2026 - Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort.
Cardiovascular research
Article2026 - Long-term outcomes of obstructive hypertrophic cardiomyopathy undergoing surgical myectomy: impact of symptom severity at presentation.
Cardiovascular research
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Epidemiological and clinical features of the 2019 novel coronavirus outbreak in ChinaPreprint516 citations2020
- 03Guiding Principles for Chronic Total Occlusion Percutaneous Coronary InterventionArticle458 citations2019
- 04
- 05Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery DiseaseArticle252 citations2015
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
- M.D.
University of Melbourne (medical degree)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
Editorial & leadership roles
journal and society appointments- Fellow
Royal Australasian College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
- Member
scientific advisory board, International Academy of Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
Media & interviews
press, podcasts and appearances- Cardiac Consult (Cleveland Clinic podcast for healthcare professionals)
episode 'Infective Endocarditis Diagnosis and Management', dated August 20, 2026, with Bo Xu, MD, and Shinya Unai, MD
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buzzsprout.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Nissen, MD
Cleveland Clinic
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)